Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $2.1 million.

  • Puma Biotechnology's Other Non-Current Assets fell 578.73% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 578.73%. This contributed to the annual value of $2.1 million for FY2024, which is 2318.95% down from last year.
  • As of Q3 2025, Puma Biotechnology's Other Non-Current Assets stood at $2.1 million, which was down 578.73% from $2.1 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Other Non-Current Assets high stood at $12.2 million for Q1 2021, and its period low was $2.1 million during Q4 2024.
  • For the 5-year period, Puma Biotechnology's Other Non-Current Assets averaged around $4.6 million, with its median value being $2.6 million (2022).
  • Per our database at Business Quant, Puma Biotechnology's Other Non-Current Assets crashed by 7868.85% in 2022 and then skyrocketed by 1184.62% in 2023.
  • Over the past 5 years, Puma Biotechnology's Other Non-Current Assets (Quarter) stood at $12.2 million in 2021, then crashed by 78.69% to $2.6 million in 2022, then increased by 5.15% to $2.7 million in 2023, then decreased by 23.19% to $2.1 million in 2024, then changed by 0.0% to $2.1 million in 2025.
  • Its Other Non-Current Assets was $2.1 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.1 million in Q1 2025.